Placebo Comparator: Vehicle

DRUG3 trials

Sponsors

Bausch & Lomb Incorporated, Surface Ophthalmics, Inc., Reistone Biopharma Company Limited

Conditions

Dry Eye DiseaseDry Eye SyndromeVitiligo

Phase 2

Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome

CompletedNCT01163643

Bausch & Lomb IncorporatedDry Eye Syndrome

Start: 2010-07-31End: 2011-07-31Updated: 2020-09-25

A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease

CompletedNCT04734197

Surface Ophthalmics, Inc.Dry Eye Disease

Start: 2021-01-11End: 2022-03-25Updated: 2025-05-11

Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo

TerminatedNCT04774809

Reistone Biopharma Company LimitedVitiligo

Start: 2020-01-29End: 2022-03-21Updated: 2022-07-13